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Abstract Stathmin is a regulator of microtubule dynamics 
which undergoes extensive phosphorylation during the cell cycle 
as well as in response to various extracellular factors. Four serine 
residues are targets for protein kinases: Ser-25 and Ser-38 for 
proline-directed kinases such as mitogen-activated protein kinase 
and cyclin-dependent protein kinase, and Ser-16 and Ser-63 for 
cAMP-dependent protein kinase. We studied the effect of 
phosphorylation on the microtubule-destabilizing activity of 
stathmin and on its interaction with tubulin in vitro. We show 
that triple phosphorylation on Ser-16, Ser-25, and Ser-38 
efficiently inhibits its activity and prevents its binding to tubulin. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The microtubule (MT) cytoskeleton plays a wide variety of 
structural and functional roles in cells, affecting their shape 
and motility, organizing the spatial distribution of organelles 
in the cytoplasm and chromosome segregation during mitosis, 
and integrating transmembrane signals. Thus the behavior of 
microtubules is influenced by many different microtubule-in-
teracting proteins (for review see [1,2]). The characteristic 
property of microtubules, known as dynamic instability, in-
volves rapid transitions between polymerization and depolym-
erization of a- and ß-tubulin heterodimers. A large group of 
proteins, collectively known as microtubule-associated pro-
teins (MAPs), favor MT polymerization thereby stabilizing 
them. Phosphorylation of MAPs decreases their stabilizing 
effect probably by reducing their direct binding to MTs 
[3,4]. More recently, another type of cellular factors has 
been identified that increase the frequency of catastrophes 
(transitions from growth to shrinkage of MTs) and therefore 
destabilize MTs in vitro and in intact cells [5-7]. These newly 
characterized proteins are encoded by the stathmin gene fam-
ily. Stathmin is a small cytosolic protein of 19 kDa that has 
been independently identified by several groups as a phospho-
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protein and is also called Opl8, metablastin, pl9, pl8, and 
prosolin (for review see [8]). In addition to its phosphorylation 
induced by a diverse number of extracellular signals [8], its 
phosphorylation state varies during the cell cycle and peaks 
during mitosis [9,10]. Stathmin is mainly expressed in prolif-
erating cells but also in developing neurons at high levels 
[11,12]. In PC 12 cells, stathmin is a physiological substrate 
for mitogen-activated protein kinase (MAP kinase) upon 
nerve growth factor induction and inhibition of its expression 
with antisense oligonucleotides prevents nerve growth factor-
induced differentiation [13]. These data suggested that stath-
min may be involved in the regulation of the rearrangement of 
the microtubule cytoskeleton during morphogenesis in re-
sponse to phosphorylation signals. 
The known in vivo phosphorylation sites of stathmin are 
Ser-16 for Ca2+/calmodulin-dependent kinase IV/Gr [14], Ser-
16 and Ser-63 for cyclic AMP-dependent protein kinase 
(PKA) [15], and Ser-25 and Ser-38 for the proline-directed 
kinases p34cdc2 [15,16] and MAP kinase [16,17]. Recent re-
ports using several phosphorylation site mutants for cell 
transfection or microinjection have indicated that the MT 
depolymerizing activity of stathmin is controlled by phospho-
rylation [6,18,19]. However, it was not known how phospho-
rylation on the different sites regulates the activity of stathmin 
and whether the effect is direct by modulating its interaction 
with tubulin heterodimers [5] or indirect through its interac-
tion with other cellular factors. 
Here we have analyzed whether phosphorylation of stath-
min alters its MT assembly properties using recombinant pu-
rified stathmin in an in vitro assay of MT polymerization and 
whether phosphorylation influences its binding to tubulin. We 
show that multiple phosphorylation of stathmin decreases its 
activity in vitro in the absence of additional factors and in-
hibits its interaction with tubulin. 
2. Materials and methods 
2.1. Preparation of recombinant stathmin and in vitro phosphorylation 
Human stathmin was expressed in Escherichia coli and purified 
from the soluble cell fraction by sequential chromatography on Q-
Sepharose, hydroxylapatite, phenyl-Sepharose and FPLC Mono Q. 
The pool from the Mono Q column was homogeneous on SDS-
PAGE and over 98% pure on RP-HPLC. The purified protein was 
dialyzed against 20 mM Tris-HCl, pH 7.5 and stored at -80°C. The 
in vitro phosphorylation was performed as described earlier [20] with 
the following modifications. In each assay 0.3 mg of stathmin was 
used in a total volume of 70 ul. For phosphorylation with MAP 
kinase (p42, UBI), 1 (ig kinase was used; for PKA (protein kinase 
A catalytic subunit, Boehringer Mannheim) 60 mU; for p34cdc2 kinase 
(Promega) 40 U. In the phosphorylation with a combination of MAP 
kinase and PKA, 1 ug MAP kinase and 60 mU PKA were used. The 
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reaction mixtures were incubated at 35°C for 3 h and the reactions 
were stopped by freezing at —80°C. Phosphorylated stathmin was 
separated from unphosphorylated protein on FPLC Mono Q. A 
1 ml Mono (5/5) column was equilibrated in 25 mM Tris-HCl, 0.5 
mM MgCl2, pH 7.5. The samples were diluted to 1 ml in equilibration 
buffer and applied to the column. Stathmin was eluted from the col-
umn with a linear gradient of 10-30% of 0.5 M NaCl in equilibration 
buffer. Phosphorylated stathmin was detected by native PAGE, 
pooled, concentrated and dialyzed against 110 mM MES, 1 mM 
EGTA, 5 mM MgCl2, pH 6.6. Protein concentrations were deter-
mined by the Lowry method [21] and the samples were stored at 
-80°C. 
2.2. Purification of microtubules and in vitro assembly 
Microtubules were prepared from porcine cerebrum by three tem-
perature-dependent cycles of cold and warm centrifugations in assem-
bly and disassembly buffer A (0.1 M MES, 1 mM EGTA, 0.5 mM 
MgCl2, pH 6.4). For assembly, 1 mM GTP was added to buffer A 
[22], This preparation of MTs was ca. 90% pure. For the cross-link-
ing, MTs were further purified to obtain pure tubulin: MTs were 
resuspended at a concentration of 20 mg/ml in buffer A, and tubulin 
was separated from MAPs by ion exchange chromatography using a 
5 ml P l l phosphocellulose column pre-equilibrated with buffer A. 
MAPs were eluted by a 15 ml linear gradient of 0-1 M NaCl in buffer 
A [23]. Protein concentration was determined by Bio-Rad protein 
assay with bovine serum albumin as standard. The assembly rate of 
tubulin was measured using a light scattering assay [24]. Tubulin was 
used at a concentration of 4 mg/ml. Absorbance was measured at 350 
nm in a Camspec M350 spectrophotometer equipped with seven 50 ul 
cuvettes and a cooling block for temperature control. 
2.3. Cross-linking of stathmin and tubulin, immunoblotting 
Cross-linking experiments were performed as described previously 
[18] with slight modifications: stathmin (2 (xM) and tubulin (10 uM) 
were incubated for 2 h at 4°C in 15 ul PEM buffer (80 mM PIPES 
(Sigma), 1 mM EDTA, 1 mM MgCl2, pH 6.8). The zero-length cross-
linker l-ethyl-3(3-dimethylaminopropyl) carbodiimide (EDC, Sigma) 
was added at a concentration of 1 mM and samples were incubated at 
18°C for durations indicated in the figure legend. In the experiments 
using phosphorylated stathmin, samples were treated for 30 min with 
EDC. The reaction was then stopped with an equal volume of 2 X 
protein sample buffer and samples were analyzed by SDS-PAGE (8-
16%) and immunoblotted. Immunoblots were immersed in blocking 
solution consisting of 5% milk powder in PBS/0.15% Tween-20. Mem-
branes were subsequently incubated with primary antibodies diluted 
in 2.5% milk powder in PBS and the signals were detected using the 
ECL Western blotting kit (Amersham International, Buckingham-
shire, UK). The rabbit antiserum against stathmin (anti-Opl8:34-
149) was a gift of M. Gullberg (Umeâ, Sweden). Mouse monoclonal 
antibody against tubulin (B5-1-2) was from Sigma. 
3. Results 
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Fig. 1. Effect of stathmin phosphorylation on the assembly of MTs 
in vitro. A: Dose-dependent inhibition of MT assembly by unphos-
phorylated stathmin. Tubulin (4 mg/ml) was incubated at 4°C in the 
absence of stathmin (control) or in the presence of 1, 3 and 5 uM 
stathmin. MT polymerization was induced by changing the tempera-
ture to 37°C at time zero. Assays were performed in duplicate. 1, 3, 
and 5 uM stathmin resulted in inhibitions of about 27%, 71%, and 
87%, respectively. B: Inhibition of MT assembly measured after 26 
min polymerization in the presence of 3 uM stathmin unphosphoryl-
ated or phosphorylated by kinases as indicated. Phosphorylated resi-
dues are indicated at the top of the bars. Values are means 
(±S.E.M., n = l) with three different batches of phosphorylated 
samples (*P<0.05; **p< 0.001). Phosphorylation by PKA alone or 
in combination with MAPK reduces the MT-depolymerizing activity 
of stathmin 2- or 3-fold, respectively. 
3.1. Effect of phosphorylation of stathmin on inhibition of MT 
assembly 
Fig. 1A illustrates that stathmin inhibited M T assembly in 
the in vitro polymerization assay in a dose-dependent manner. 
To study the effect of phosphorylation on the ability of stath-
min to inhibit microtubule polymerization, the recombinant 
protein was phosphorylated in vitro using M A P kinase, 
p34cdc2 kinase and P K A . The specific sites phosphorylated 
by these kinases were determined by a rapid digestion tech-
nique in combination with ESI-MS [25] (data not shown). In 
agreement with previous reports [15-17], the sites for M A P 
kinase and p34c d c 2 kinase were Ser-25 and Ser-38 and for 
P K A Ser-16 and Ser-63. In addition, stathmin was multi-
phosphorylated by the combined use of M A P K and PKA. 
After the phosphorylation, the samples were not homogene-
ous but contained unphosphorylated protein. Therefore, the 
phosphorylated stathmin was isolated by ion exchange chro-
matography on M o n o Q. This purification step also removed 
the kinases from the protein preparations. After purification, 
no unphosphorylated stathmin was detectable on native 
P A G E . The M A P kinase phosphorylated sample was mainly 
mono-phosphorylated on Ser-25 with some di-phosphoryla-
tion ( < 2 5 % ) on Ser-25 and Ser-38, the P K A sample was 
di-phosphorylated on Ser-16 and Ser-63, and the p34c d c 2 kin-
ase sample was di-phosphorylated on Ser-25 and Ser-38. The 
sample phosphorylated with both M A P kinase and P K A was 
mainly tri-phosphorylated with traces of di-phosphorylated 
protein (data not shown). To demonstrate the effect of the 
different phosphorylated forms on the inhibition of M T as-
sembly, the proteins were used at a concentration of 3 JJ.M at 
which unphosphorylated stathmin caused about 80% inhibi-
tion (Fig. IB). The effect of phosphorylation was also tested 
at other concentrations (1 u M and 5 uM) at which the differ-
ences between unphosphorylated stathmin and the phospho-
forms were found to be less strong (not shown). Fig. IB shows 
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Fig. 2. Effect of stathmin phosphorylation on tubulin binding in vi-
tro. A: Western blot analysis of stathmin-tubulin complexes follow-
ing chemical cross-linking with the zero-length cross-linker EDC. 
Tubulin alone or in the presence of stathmin was treated with 1 mM 
EDC for 0, 15 and 30 min as indicated. Membranes were immuno-
blotted with anti-a-tubulin or anti-stathmin antibodies. B: Western 
blot analysis with anti-stathmin antibodies of stathmin-tubulin com-
plexes after phosphorylation by kinases as indicated. Samples were 
incubated for 30 min in the presence of EDC. (The lower band of 
the stathmin doublet corresponds to a specific degradation product 
starting at amino acid 14 in the stathmin sequence [20] and was 
found to inhibit in vitro MT polymerization indistinguishable from 
the full length protein; unpublished results). A densitometric quanti-
fication of tubulin binding is shown in the histogram below. The 
values are expressed as percentage of unphosphorylated stathmin 
binding to tubulin. Values are means ( ± S.E.M., n = 3). 
that phosphorylation on the site for proline-directed kinases 
(Ser-25 and Ser-38) had no statistically significant effect on the 
activity of stathmin. However, phosphorylation at Ser-16 and 
Ser-63 significantly reduced the ability of stathmin to inhibit 
MT assembly. The percentage of MT polymerization in-
creased from 20% to 46% (P<0.05). The most potent reduc-
tion in activity was observed when stathmin was phosphoryl-
ated on both MAP kinase (Ser-25) and PKA (Ser-16 and Ser-
63) sites (P< 0.001) demonstrating that simultaneous phos-
phorylation of both MAP kinase and PKA sites enhances 
the downregulation of stathmin activity. 
3.2. Effect of phosphorylation on stathmin-tubulin complex 
formation 
Stathmin has been shown to physically interact with tubulin 
dimers [5] and to form a complex with oc-tubulin upon chem-
ical cross-linking with the zero-length cross-linker EDC [18]. 
By this cross-linking method, we studied the effect of phos-
phorylation on the interaction of stathmin with tubulin. The 
results show that unphosphorylated stathmin formed an ad-
duct of 75 kDa that reacted with both stathmin and oc-tubulin 
antibodies (Fig. 2A) but not with ß-tubulin antibodies which 
is consistent with previous reports by Melander Gradin et al. 
[18]. The size of this product corresponded approximately to 
the sum of stathmin (19 kDa) and a-tubulin (55 kDa). The 
adduct of 75 kDa did not appear in the absence of tubulin nor 
was a binding of stathmin to actin observed (not shown). 
Each phosphorylation caused a decrease in the amount of 
stathmin binding to tubulin (Fig. 2B). A pronounced de-
creased in complex formation was seen after phosphorylation 
at the PKA sites (Ser-16 and -63), and phosphorylation on 
both the MAP kinase and PKA sites (Ser-16, -25, -63) nearly 
abolished stathmin-tubulin complex formation. 
4. Discussion 
To study potential regulatory mechanisms of stathmin func-
tion, we have tested recombinant stathmin protein produced 
in E. coli and several phosphoisoforms in an in vitro MT 
polymerization assay. Phosphorylation on the sites for pro-
line-directed kinases (Ser-25 and Ser-38) did not significantly 
reduce stathmin activity. However, stathmin containing phos-
phorylation on the PKA sites Ser-16 and Ser-63 was signifi-
cantly less active than the unphosphorylated protein indicat-
ing that phosphorylation on Ser-16 and Ser-63 is crucial for 
this effect. This observation is consistent with the findings of 
Horwitz et al. [19] in intact cells where microinjection of re-
combinant protein containing a Ser to Asp mutation to mimic 
phosphorylation at Ser-63, but not on both Ser-25 and Ser-38, 
prevented the loss of the MT network induced by stathmin. 
The downregulation of stathmin activity was enhanced 
when stathmin was simultaneously phosphorylated on the 
MAP kinase (Ser-25) and PKA (Ser-16 and Ser-63) sites. 
These data suggest that stathmin activity is regulated by phos-
phorylation by at least two different protein kinase signalling 
pathways. Interestingly, ectopic expression of stathmin mu-
tants, substituted by alanine either at Ser-25 and Ser-38, or 
at Ser-16 and Ser-63, both resulted in a block in cell division 
[26,27] suggesting that multi-site phosphorylation of stathmin 
is required for normal cell division. Our observations are in 
agreement with findings of Horwitz et al. [19] who reported 
that non-phosphorylatable mutant recombinant proteins, 
when injected into cells, are more active than the wild-type 
protein in reducing the MT network. However, this study [19] 
using glutathione S-transferase-stathmin fusion protein, re-
ported that Ser to Asp substitution on all four sites did not 
alter the activity of stathmin to block tubulin assembly in 
vitro. Because these mutants had nevertheless a dramatic ef-
fect in intact cells, the authors proposed the requirement of 
additional cellular factors for the regulation of stathmin ac-
tivity. 
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Here we have shown that phosphorylation directly down-
regulates the ability of stathmin to inhibit M T polymerization. 
Moreover, we have demonstrated that the downregulation of 
the activity closely correlates with the ability of stathmin to 
form a complex with tubulin. While stathmin containing 
phosphorylation at the proline-directed kinase sites was able 
to bind tubulin, al though at a reduced level, phosphorylation 
at Ser-16 and Ser-63 strongly reduced stathmin-tubulin com-
plex formation. Phosphorylat ion on three sites (Ser-16, Ser-25, 
Ser-63) completely inhibited the tubulin binding. It is of note 
that the amplitude of the differences observed between the 
isoforms is smaller in the in vitro polymerization assay than 
in the binding assay which may be due to differences in the 
sensitivity of the assays. Nevertheless, in both assays, Ser-16 
and Ser-63 appeared to be the crucial phosphorylation sites 
al though concomitant phosphorylation of a third residue, Ser-
25, further increased the effect. In summary, our data suggest 
that multiple phosphorylation of stathmin downregulates its 
activity by blocking its binding to tubulin heterodimers. The 
precise cellular function of stathmin in proliferating cells or 
during neuronal differentiation is not yet understood. How-
ever, it is likely that stathmin is involved in the reorganization 
of microtubules and that its microtubule-destabihzing activity 
is regulated by protein kinase systems in response to extra-
cellular signals. 
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